CT-DPACC for AMP SCZ: Coordinating Big Data to Understand and Prevent Schizophrenia
Official title: Clinical Trial Data Processing, Analysis, and Coordination Center (CT-DPACC) for Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Project
Funded at Brigham and Women's Hospital · NIH-11533656 · Data updated 2026-11-12
A nationwide effort will process and analyze data from a large schizophrenia study to help scientists find patterns that could prevent psychosis in young people at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | June 17, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $119,268 |
| NIH project number | 3U24MH137171-03S1 |
| Project ID | NIH-11533656 on NIH RePORTER |
Who could benefit from this research
✓Could help
Young people at clinical high risk for psychosis or in the early stages of psychosis who may contribute data or be candidates for future trials.
✕Less likely to help
Patients not enrolled in or directly related to the AMP SCZ data-sharing and biomarker efforts may not receive immediate clinical benefits.
What this research studies
This project provides a centralized data processing and coordination center for AMP SCZ, handling large-scale data from multiple studies to enable deeper insights. It focuses on harmonizing data, applying advanced bioinformatics methods, and coordinating researchers to accelerate discovery of biomarkers and drug-development tools. By making data more usable and comparable, clinicians and patients could benefit from faster progress toward better prevention and treatment strategies for psychosis risk.
Why it matters
Potential benefit: If successful, the work could speed up identification of early warning signs and improve prevention strategies for psychosis.
How similar studies have gone: Prior efforts have shown that standardized data protocols and robust biomarkers can improve drug development and risk stratification in psychiatric conditions.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Shenton, Martha E. — Brigham and Women's Hospital
- Study coordinator: Shenton, Martha E.
Related research
Other NIH-funded projects on the same topics.
-
Understanding social disconnection in schizophrenia using digital signals and brain data
This grant explores how smartphones, social networks, and brain imaging can reveal why Veterans with schizophrenia have trouble forming and maintaining relationships, with the goal of guiding better treatments.
-
Understanding how autism and schizophrenia risk genes affect brain development
Scientists are testing how mutations in certain autism and schizophrenia risk genes change brain cells and networks, using patient-derived cells and organoids.
-
Digital support to spread team-based schizophrenia care in primary care in India
A project to help frontline health workers in India use digital tools to provide coordinated schizophrenia care in primary care, with plans to inform care in the United States as well.
-
Digital support for shared-care of schizophrenia in primary care in India
A patient-friendly plan to bring evidence-based schizophrenia care to primary care in India using digital tools and trained frontline workers.
-
Digital support to scale Schizophrenia care in primary care in India
A nationwide effort to help primary care teams in India deliver better, more accessible schizophrenia care using digital tools and trained frontline workers.
-
How social isolation affects aging health in schizophrenia
This project explores how being socially isolated may speed up health problems as people with schizophrenia age.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.